The human body possesses an endogenous cannabinoid system featuring CB1 and CB2 receptors that naturally bind to compounds like anandamide to regulate pain, stress, and inflammation. Exogenous THC mimics these effects but varies significantly in potency based on the delivery method; ingested THC undergoes first-pass metabolism in the liver to become 11-hydroxy-THC, a highly psychoactive compound that crosses the blood-brain barrier more effectively than inhaled Delta-9 THC. Chronic activation of these receptors can lead to cannabinoid hyperemesis syndrome, a condition characterized by severe vomiting that often responds to heat or capsaicin due to vanilloid receptor involvement. Furthermore, synthetic cannabinoids like K2 or Spice pose greater clinical risks than natural cannabis, frequently causing seizures, tachycardia, and acute kidney injury. While the exact mechanism of acetaminophen remains elusive, current research suggests it may achieve analgesic effects by partially binding to CB2 receptors.
Sign in to continue reading, translating and more.
Open full episode in Podwise